Commercially available bone graft substitutes: the impact of origin and processing on graft functionality

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Orthopedic Research

Background:

• Effective bone tissue engineering grafts are crucial for regenerative medicine.
• The dynamic nature of bone presents challenges in developing ideal grafting materials.
• Autogenous bone remains the gold standard, but limitations exist.

Purpose of the Study:

• To review commercially available bone graft materials.
• To analyze graft characteristics influencing tissue repair effectiveness.
• To compare advantages and disadvantages of allogenic, xenogeneic, and synthetic grafts.

Main Methods:

• Web-based search for clinically applicable bone graft materials.
• Categorization of grafts by material source (allogenic, xenogeneic, synthetic).
• Review of existing literature on graft composition, origin, and performance.

Main Results:

• Autogenous bone is the current gold standard, though not without drawbacks.
• Allogenic, xenogeneic, and synthetic materials offer varying benefits and limitations.
• Bioactive molecules can enhance the osteobiologic capacity of traditional bone grafts.

Conclusions:

• No single bone graft material is ideal; selection depends on clinical application.
• Understanding material source and composition is key to optimizing bone repair.
• Bioactive molecule incorporation shows promise for improving bone graft efficacy.